Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The genetics of multiple sclerosis: an up-to-date review.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
UCSF Neuroimmunology Research Seminar
Intermittent Atrioventricular Block following Fingolimod Initiation.
Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
Self-Reported Fatigue and Energy Cost During Walking Are Not Related in Patients With Multiple Sclerosis.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Modeling the heterogeneity of multiple sclerosis in animals.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Substance Name: Phenytoin
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Back on the scent: the olfactory system in CNS demyelinating diseases.
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Imaging of the spine at 3 tesla.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
Olfactory dysfunction in multiple sclerosis.
Pages
« first
‹ previous
…
194
195
196
197
198
199
200
201
202
…
next ›
last »